Detalles de la búsqueda
1.
Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study.
BMC Cancer
; 24(1): 393, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38549044
2.
Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion.
BMC Pulm Med
; 24(1): 89, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365707
3.
Insights on the ERS/ESTS statement on the management of pleural infection in adults.
Eur Respir J
; 63(3)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485181
4.
Characteristics of genomic alterations of lung adenocarcinoma in young never-smokers.
Int J Cancer
; 143(7): 1696-1705, 2018 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29667179
5.
[The Diagnostic Value of Endobronchial Ultrasound-guided Needle Aspiration Biopsy for Lung or Mediastinal Lymph Node Cancer and Tuberculosis].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 48(3): 347-351, 2017 May.
Artículo
en Zh
| MEDLINE | ID: mdl-28616904
6.
[Progress on Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi
; 27(2): 138-146, 2024 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38453446
7.
Efficacy of targeted therapy in patients with non-small cell lung cancer harboring very rare mutations in EGFR exon 18.
Transl Lung Cancer Res
; 13(4): 875-884, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736500
8.
The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancer.
MedComm (2020)
; 5(6): e604, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38840771
9.
[Advances of Immunotherapy Resistance and Coping Strategies â©in Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi
; 26(1): 66-77, 2023 Jan 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36792083
10.
High PD-L1 Expression Correlates with an Immunosuppressive Tumour Immune Microenvironment and Worse Prognosis in ALK-Rearranged Non-Small Cell Lung Cancer.
Biomolecules
; 13(6)2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37371571
11.
Cost-effectiveness evaluation based on two models of first-line atezolizumab monotherapy and chemotherapy for advanced non-small cell lung cancer with high-PDL1 expression.
Front Oncol
; 13: 1093469, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998459
12.
Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case report.
Immunotherapy
; 15(2): 77-83, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695105
13.
The clinical features and prognosis of fungal pleural infection: A case series and literature review.
Medicine (Baltimore)
; 102(48): e36411, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050212
14.
Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion.
Clin Respir J
; 17(11): 1158-1168, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37723659
15.
[Peripheral Blood Laboratory Test Results Combined with TCF1+CD8+ T Lymphocytes â©Ratio to Predict the Response and Prognosis of Immunotherapy to â©Advanced Lung Cancer].
Zhongguo Fei Ai Za Zhi
; 26(8): 605-614, 2023 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37752540
16.
Superior clinical outcomes in patients with non-small cell lung cancer harboring multiple ALK fusions treated with tyrosine kinase inhibitors.
Transl Lung Cancer Res
; 12(9): 1935-1948, 2023 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854161
17.
Tislelizumab plus chemotherapy for patients with EGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37597849
18.
Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
J Immunother Cancer
; 11(9)2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37730276
19.
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study.
Lancet Respir Med
; 11(10): 905-915, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244266
20.
[Advances in the Study of Tissue-resident Memory T Cells in Lung Cancer].
Zhongguo Fei Ai Za Zhi
; 25(12): 862-869, 2022 Dec 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36617472